Sloan-Kettering Says Niro Attys Filched Gene Therapy Docs

By Kali Hays · November 4, 2016, 3:43 PM EDT

The Sloan-Kettering Institute for Cancer Research on Thursday called for sanctions against an independent biopharmaceutical company trying to get back certain rights to a type of gene therapy for a blood...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015

Recent Articles By Kali

January 19, 2017
CVS Loses 275 Legal Hours In EEOC's Failed Title VII Row
January 12, 2017
Latham Attorneys Escape Sanctions In Craigslist IP Row
December 06, 2016
Lewis Brisbois Nabs 2 Ethics Pros From Eccleston and Wolf
December 05, 2016
K&L Gates Adds Ex-Linklaters, Llinks Law Attys In Shanghai
December 01, 2016
Pa.'s Role In Merger Suit Doesn't Warrant Fees, Hospital Says
October 04, 2016
Accountant Ducks Buchanan's Negligence Claims In AFL Row
September 22, 2016
Ohio Attys Now Safe To Advise On Legal Marijuana Activity
September 21, 2016
Fla. Judge Won't Sanction Quinn Emanuel In FCA Suit
September 16, 2016
Health Co. Execs Say $20M LeClairRyan Deal Too Broad
September 15, 2016
Whistleblower Fights Sanctions Bid Against Quinn Emanuel